CASI Pharmaceuticals says SVP Wei (Larry) Zhang steps down

CASI Pharmaceuticals announced that Senior Vice President Wei (Larry) Zhang is stepping down from his role. This personnel change is part of the company's broader efforts to streamline its branches, personnel, and related activities within the United States.

CASI Pharmaceuticals reported that Wei (Larry) Zhang will no longer serve as senior vice president. * The move was tied to efforts to streamline branches, personnel, and related activities in the United States. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CASI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-095969), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here